These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Cost of care according to disease-modifying therapy in Mexicans with relapsing-remitting multiple sclerosis. Macías-Islas MA; Soria-Cedillo IF; Velazquez-Quintana M; Rivera VM; Baca-Muro VI; Lemus-Carmona EA; Chiquete E Acta Neurol Belg; 2013 Dec; 113(4):415-20. PubMed ID: 23670405 [TBL] [Abstract][Full Text] [Related]
23. Effects of glatiramer acetate on spasticity in previously interferon-beta-treated and treatment-naive patients with relapsing-remitting multiple sclerosis: a prospective, nonrandomized, open-label, uncontrolled, observational pilot study. Meca-Lallana JE; de Mingo-Casado P; Amorin-Díaz M; Martínez-Navarro ML; Barreiro AF Clin Ther; 2010 Jun; 32(6):1061-6. PubMed ID: 20637960 [TBL] [Abstract][Full Text] [Related]
24. Anti-depressant use in association with interferon and glatiramer acetate treatment in multiple sclerosis. Patten SB; Williams JV; Metz LM Mult Scler; 2008 Apr; 14(3):406-11. PubMed ID: 17986504 [TBL] [Abstract][Full Text] [Related]